https://www.indianpharmapost.com/transmural-systems-wins-breakthrough-fda-nod-for-coronary-saving-tavr-device-183602025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/cidara-hits-target-enrollment-for-phase-3-flu-trial-ahead-of-peak-season-183742025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/philips-next-gen-platform-lets-radiologists-work-anywhere-faster-183752025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-pharma-gets-vai-from-fda-for-monroe-facility-183762025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/eu-greenlights-dupixent-for-chronic-urticaria-offering-new-hope-to-patients-183772025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/valneva-phase-2-data-for-lyme-disease-vaccine-candidate-shows-striking-immune-response-183782025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/valneva-shifts-french-ops-to-lyon-183792025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/gavi-and-unicef-ink-agreement-to-slash-malaria-vaccine-price-183802025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/owlet-taps-opensynergys-bluetooth-tech-to-power-next-gen-baby-monitor-183812025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/otsuka-files-fda-application-for-first-in-class-adhd-drug-183822025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/nhss-breakthrough-leukaemia-therapy-set-to-transform-lives-in-uk-183832025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/medtronic-launches-first-intelligent-circular-stapler-to-boost-surgical-precision-reduce-leaks-183842025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/enlivex-reports-promising-six-month-data-for-allocetra-in-knee-osteoarthritis-183732025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/kelun-biotechs-sac-tmt-shows-breakthrough-results-in-first-line-lung-cancer-trial-183722025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/investors-pile-in-as-cordance-secures-oversubscribed-seed-round-for-brain-cancer-tech-183612025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-launches-worlds-first-nebulized-triple-therapy-for-copd-183622025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/indias-pharma-industry-showcases-innovation-global-ambitions-at-cphi-pmec-india-2025-183632025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-fast-tracks-higher-dose-obesity-drug-to-fda-183642025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/lords-mark-bets-big-on-ai-driven-dialysis-tech-buys-85-stake-in-renalyx-health-183652025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-lal-pathlabs-launches-indias-first-complement-testing-lab-183662025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/sms-pharmaceuticals-associate-company-receives-fda-approval-for-reformulated-ranitidine-183672025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-inks-licensing-commercialisation-pact-with-rk-pharma-183682025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-nod-to-astrazenecas-imfinzi-plus-flot-chemotherapy-for-early-and-locally-advanced-gastric-cancer-183692025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/dhoni-joins-arth-by-emcure-to-tackle-iron-deficiency-on-world-iron-deficiency-day-183702025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-updates-label-for-sun-pharmas-unloxcyt-highlighting-durable-responses-in-advanced-skin-cancer-183712025-11-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-fdas-tentative-approval-for-empagliflozin-and-linagliptin-tablets-183852025-11-27T00:00:00+05:30always0.9